NASDAQ, SRDX - Surmodics Inc
Our surface modification and drug delivery technologies are utilized by our
customers to alter the characteristics of the surfaces of devices and biological
materials (e.g., lubricity or hemocompatibility), create new functions for the
surfaces of the devices (e.g., drug delivery or promotion of healing), or enable
drug delivery through our microparticle, polymer implant or device platforms.
For example, our patented PhotoLink? technology enhances the maneuverability of
dilatation catheters and guidewires within the body by improving the lubricity
of the device surface. Similarly, our patented drug delivery technologies can
create new device capabilities by enabling site specific, controlled release
drug delivery in cases where devices are themselves (e.g., stents) necessary to
treat a medical condition and in cases where devices serve only as a vehicle to
deliver a drug (e.g., ophthalmology implants and drug delivery depots). ...
Read SEC Filing on NASDAQ.com »